Kevin J. Bratton
Vice President of Finance and Chief Financial Officer
Kevin J. Bratton, Vice President and CFO, joined the company in June 2009.
Mr. Bratton was most recently Senior Vice President
Business Operations for EUSA Pharma (USA), Inc. in Langhorne,
Pennsylvania. Mr. Bratton had been Senior Vice President and Chief
Financial Officer of Cytogen Corporation in Princeton, New Jersey prior
to its acquisition by EUSA Pharma, Inc. in May 2008.
Mr. Bratton has
over 35 years of experience in all phases of multi-national financial
operations across the healthcare, biotechnology and technology
industries, including developing strategic plans and annual budgets as
well as financing negotiations and merger & acquisition
transactions.
Prior to joining Cytogen, Mr. Bratton was Chief Financial
Officer at Metrologic Instruments, Inc., a global technology company,
where he directed the company's finance operations during a period of
significant growth in sales, net income, cash flow from operations, and
working capital.
Previously, Mr. Bratton worked at The JPM Company,
where he served as chief financial officer and as director of external
reporting.
Prior to joining JPM, Mr. Bratton worked for more than 20
years in the healthcare sector. He was vice president of finance and
treasurer for the biotechnology company IGI, Inc., and corporate
controller for the specialty medical company Delmed, Inc.
Mr. Bratton
began his career with the public accounting firm Touche Ross & Co.
(now Deloitte & Touche LLP). He has a bachelor of science in
business and accounting from Northeastern University.